OPKO Health PE Ratio 2010-2024 | OPK
Current and historical p/e ratio for OPKO Health (OPK) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. OPKO Health PE ratio as of April 02, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| OPKO Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-04-02 | 1.64 | 0.00 | |
| 2024-12-31 | 1.47 | $-0.09 | 0.00 |
| 2024-09-30 | 1.49 | $-0.19 | 0.00 |
| 2024-06-30 | 1.25 | $-0.33 | 0.00 |
| 2024-03-31 | 1.20 | $-0.35 | 0.00 |
| 2023-12-31 | 1.51 | $-0.25 | 0.00 |
| 2023-09-30 | 1.60 | $-0.27 | 0.00 |
| 2023-06-30 | 2.17 | $-0.27 | 0.00 |
| 2023-03-31 | 1.46 | $-0.38 | 0.00 |
| 2022-12-31 | 1.25 | $-0.44 | 0.00 |
| 2022-09-30 | 1.89 | $-0.44 | 0.00 |
| 2022-06-30 | 2.53 | $-0.29 | 0.00 |
| 2022-03-31 | 3.44 | $-0.18 | 0.00 |
| 2021-12-31 | 4.81 | $-0.05 | 0.00 |
| 2021-09-30 | 3.65 | $0.11 | 33.18 |
| 2021-06-30 | 4.05 | $0.11 | 36.82 |
| 2021-03-31 | 4.29 | $0.19 | 22.58 |
| 2020-12-31 | 3.95 | $0.05 | 79.00 |
| 2020-09-30 | 3.69 | $-0.18 | 0.00 |
| 2020-06-30 | 3.41 | $-0.33 | 0.00 |
| 2020-03-31 | 1.34 | $-0.48 | 0.00 |
| 2019-12-31 | 1.47 | $-0.53 | 0.00 |
| 2019-09-30 | 2.09 | $-0.48 | 0.00 |
| 2019-06-30 | 2.44 | $-0.42 | 0.00 |
| 2019-03-31 | 2.61 | $-0.33 | 0.00 |
| 2018-12-31 | 3.01 | $-0.27 | 0.00 |
| 2018-09-30 | 3.46 | $-0.52 | 0.00 |
| 2018-06-30 | 4.70 | $-0.55 | 0.00 |
| 2018-03-31 | 3.17 | $-0.58 | 0.00 |
| 2017-12-31 | 4.90 | $-0.56 | 0.00 |
| 2017-09-30 | 6.86 | $-0.22 | 0.00 |
| 2017-06-30 | 6.58 | $-0.17 | 0.00 |
| 2017-03-31 | 8.00 | $-0.11 | 0.00 |
| 2016-12-31 | 9.30 | $-0.07 | 0.00 |
| 2016-09-30 | 10.59 | $-0.03 | 0.00 |
| 2016-06-30 | 9.34 | $0.25 | 37.36 |
| 2016-03-31 | 10.39 | $0.14 | 74.21 |
| 2015-12-31 | 10.05 | $-0.10 | 0.00 |
| 2015-09-30 | 8.41 | $-0.22 | 0.00 |
| 2015-06-30 | 16.08 | $-0.58 | 0.00 |
| 2015-03-31 | 14.17 | $-0.55 | 0.00 |
| 2014-12-31 | 9.99 | $-0.40 | 0.00 |
| 2014-09-30 | 8.51 | $-0.32 | 0.00 |
| 2014-06-30 | 8.84 | $-0.38 | 0.00 |
| 2014-03-31 | 9.32 | $-0.33 | 0.00 |
| 2013-12-31 | 8.44 | $-0.33 | 0.00 |
| 2013-09-30 | 8.81 | $-0.29 | 0.00 |
| 2013-06-30 | 7.10 | $-0.15 | 0.00 |
| 2013-03-31 | 7.63 | $-0.18 | 0.00 |
| 2012-12-31 | 4.81 | $-0.10 | 0.00 |
| 2012-09-30 | 4.18 | $-0.04 | 0.00 |
| 2012-06-30 | 4.60 | $-0.04 | 0.00 |
| 2012-03-31 | 4.73 | $-0.02 | 0.00 |
| 2011-12-31 | 4.90 | $-0.01 | 0.00 |
| 2011-09-30 | 4.33 | $-0.08 | 0.00 |
| 2011-06-30 | 3.69 | $-0.08 | 0.00 |
| 2011-03-31 | 3.73 | $-0.09 | 0.00 |
| 2010-12-31 | 3.67 | $-0.09 | 0.00 |
| 2010-09-30 | 2.24 | $-0.12 | 0.00 |
| 2010-06-30 | 2.26 | $-0.09 | 0.00 |
| 2010-03-31 | 1.98 | $-0.09 | 0.00 |
| 2009-12-31 | 1.83 | $-0.12 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.115B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $187.725B | 22.76 |
| Intuitive Surgical (ISRG) | United States | $176.405B | 80.93 |
| Alcon (ALC) | Switzerland | $46.824B | 31.12 |
| Edwards Lifesciences (EW) | United States | $42.608B | 27.66 |
| IDEXX Laboratories (IDXX) | United States | $34.032B | 39.36 |
| IQVIA Holdings (IQV) | United States | $31.084B | 17.20 |
| DexCom (DXCM) | United States | $26.777B | 41.39 |
| Mettler-Toledo (MTD) | United States | $24.611B | 28.69 |
| STERIS (STE) | Ireland | $22.269B | 25.47 |
| Waters (WAT) | United States | $21.897B | 31.05 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.380B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.612B | 14.91 |
| Hologic (HOLX) | United States | $13.861B | 14.96 |
| Sysmex ADR (SSMXY) | Japan | $11.941B | 37.44 |
| Penumbra (PEN) | United States | $10.300B | 93.17 |
| Globus Medical (GMED) | United States | $10.068B | 23.31 |
| Masimo (MASI) | United States | $9.002B | 37.78 |
| Teleflex (TFX) | United States | $6.407B | 9.86 |
| Glaukos (GKOS) | United States | $5.567B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.967B | 22.27 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| Veracyte (VCYT) | United States | $2.311B | 41.76 |
| TransMedics (TMDX) | United States | $2.265B | 66.61 |
| Nihon Kohden (NHNKY) | Japan | $2.205B | 12.06 |
| LivaNova (LIVN) | United Kingdom | $2.135B | 12.96 |
| Elekta AB (EKTAY) | Sweden | $1.995B | 17.93 |
| Integra LifeSciences Holdings (IART) | United States | $1.698B | 8.59 |
| Alphatec Holdings (ATEC) | United States | $1.462B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.274B | 0.00 |
| Paragon 28 (FNA) | United States | $1.096B | 0.00 |
| Artivion (AORT) | United States | $1.034B | 98.32 |
| RxSight (RXST) | United States | $1.022B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| AxoGen (AXGN) | United States | $0.820B | 0.00 |
| IRadimed (IRMD) | United States | $0.667B | 34.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 10.61 |
| Mesa Laboratories (MLAB) | United States | $0.645B | 14.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.636B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.598B | 0.00 |
| SiBone (SIBN) | United States | $0.596B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.531B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.525B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.425B | 0.00 |
| NeuroPace (NPCE) | United States | $0.400B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.380B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.351B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.37 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| CVRx (CVRX) | United States | $0.318B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.313B | 16.73 |
| Nevro (NVRO) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Accuray (ARAY) | United States | $0.184B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.177B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| 908 Devices (MASS) | United States | $0.158B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.123B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.117B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.114B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 11.82 |
| EDAP TMS S.A (EDAP) | France | $0.073B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.052B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.027B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |